EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Familial NSD1 Exon 3 Deletion Associated with Phenotypic and Epigenetic Variability

Sunwoo Liv Lee iD, Alison Foster, Dalit May iD, Ciara Batterton, Eguzkine Ochoa, Bryndis Yngvadottir iD, Ruth Armstrong, Meena Balasubramanian iD, Mary O'Driscoll, Marc Tischkowitz iD, France Docquier, Fay Rodger und 3 weitere

Genes · 2025

DOI: 10.3390/genes16101190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Sunwoo Liv Lee und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Medicine, University of Cambridge, Cambridge CB2 0QQ, UK. Hauptthemen laut MEDLINE: Histone-Lysine N-Methyltransferase, Sotos Syndrome, Epigenesis, Genetic, Sequence Deletion. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Cambridge Biomedical Research Centre, NIHR Rare Disease Translational Research Collaboration, Rosetrees Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Germline pathogenic variants in NSD1 cause Sotos syndrome, a developmental disorder characterised by overgrowth, intellectual disability, macrocephaly, developmental anomalies, and, in some cases, tumour development. Familial cases of Sotos syndrome are rare and genotype–phenotype correlations are not well described. NSD1, a lysine-specific histone methyltransferase, is an important epigenetic regulator and pathogenic variants in NSD1 are associated with a distinctive blood DNA methylation pattern (episignature). We described a family with an NSD1 exon 3 deletion and an atypical clinical phenotype.

Methods

DNA episignature profiling was undertaken with a next generation sequencing-based approach.

Results

Within the family, the three affected individuals showed clinical variability with the proband being most severely affected, although none showed unequivocal macrocephaly or the characteristic facial features of Sotos syndrome. DNA methylation profiling was performed in the three affected family members, eight individuals with Sotos syndrome, and compared to control samples. The eight individuals with Sotos syndrome displayed genome-wide hypomethylation as previously described. DNA hypomethylation was also apparent in the three family members with the NSD1 exon 3 deletion with the proband being most similar to the episignature observed in confirmed Sotos syndrome patients. The two more mildly affected relatives had less pronounced DNA hypomethylation.

Conclusions

A familial germline exon 3 NSD1 deletion was associated with mild Sotos syndrome phenotype with variable expressivity and a DNA methylation episignature that was less marked in milder cases than in individuals with classical Sotos syndrome. These findings support the use of methylation episignature analysis to explore intrafamilial variability in chromatin disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone-Lysine N-MethyltransferaseSotos SyndromeEpigenesis, GeneticSequence DeletionHumansMaleFemaleExonsPhenotypeDNA MethylationPedigreeChildAdultChild, PreschoolAdolescent

Stichwörter der Autor:innen

DNA methylationNSD1atypical sotos syndromedevelopmental disorderepisignaturesotos syndrome

Substanzen

NSD1 protein, humanHistone-Lysine N-Methyltransferase

Autor:innen und Institutionen

  • Department of Genomic Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Clinical Genetics Unit, Birmingham Women's and Children's NHS Trust, Birmingham B15 2TG, UK.
  • Peninsula Clinical Genetics, Royal Devon and Exeter NHS Trust, Exeter EX1 2ED, UK.
  • West Midlands Genomics Laboratory, Birmingham Women's and Children's NHS Trust, Birmingham B15 2TG, UK.
  • Department of Clinical Genetics, Cambridge University Hospitals NHS Trust, Cambridge CB2 0QQ, UK.
  • Division of Clinical Medicine, University of Sheffield, Sheffield S10 2RX, UK.

ORCID-Profile: Sunwoo Liv Lee, Dalit May, Bryndis Yngvadottir, Meena Balasubramanian, Marc Tischkowitz, Ana Toribio, Eamonn R Maher

Förderung

  • NIHR Cambridge Biomedical Research Centre
  • NIHR Rare Disease Translational Research Collaboration
  • Rosetrees Trust
  • EpiGenRare MRC Rare Diseases Node

Zitieren

APA

Lee, S. L., Foster, A., May, D., Batterton, C., Ochoa, E., Yngvadottir, B., Armstrong, R., Balasubramanian, M., O'Driscoll, M., Tischkowitz, M., Docquier, F., Rodger, F., Martin, E., Toribio, A., & Maher, E. R. (2025). Familial NSD1 Exon 3 Deletion Associated with Phenotypic and Epigenetic Variability. Genes. https://doi.org/10.3390/genes16101190

Vancouver

Lee SL, Foster A, May D, Batterton C, Ochoa E, Yngvadottir B, et al. Familial NSD1 Exon 3 Deletion Associated with Phenotypic and Epigenetic Variability. Genes. 2025. doi:10.3390/genes16101190

BibTeX
@article{Lee2025,
  author = {Lee, Sunwoo Liv and Foster, Alison and May, Dalit and Batterton, Ciara and Ochoa, Eguzkine and Yngvadottir, Bryndis and Armstrong, Ruth and Balasubramanian, Meena and O'Driscoll, Mary and Tischkowitz, Marc and Docquier, France and Rodger, Fay and Martin, Ezequiel and Toribio, Ana and Maher, Eamonn R},
  title = {Familial NSD1 Exon 3 Deletion Associated with Phenotypic and Epigenetic Variability},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16101190}
}
Kostenlos starten →